In recent weeks, global markets have experienced mixed performances, with major U.S. indices such as the S&P 500 and Nasdaq Composite advancing, while the S&P MidCap 400 declined and the Russell 2000 remained relatively unchanged. Amid these fluctuations, small-cap stocks continue to attract attention from investors seeking opportunities in a volatile environment characterized by steady interest rates and shifting economic indicators. Identifying potentially undervalued small-cap stocks can be particularly appealing in this context as they may offer growth potential when supported by insider buying activity.
| Name | PE | PS | Discount to Fair Value | Value Rating |
|---|---|---|---|---|
| Eurocell | 12.0x | 0.3x | 47.14% | ★★★★★☆ |
| Nederman Holding | 18.3x | 0.8x | 27.06% | ★★★★★☆ |
| NoHo Partners Oyj | 16.7x | 0.4x | 34.58% | ★★★★★☆ |
| Bilia | 16.7x | 0.3x | 30.58% | ★★★★☆☆ |
| Bytes Technology Group | 18.2x | 4.2x | 12.41% | ★★★★☆☆ |
| Nexus Industrial REIT | 10.1x | 3.4x | 8.34% | ★★★★☆☆ |
| CellaVision | 27.2x | 4.7x | 43.72% | ★★★☆☆☆ |
| Pizza Pizza Royalty | 13.8x | 10.5x | 33.22% | ★★★☆☆☆ |
| Primaris Real Estate Investment Trust | 20.8x | 3.9x | 45.41% | ★★★☆☆☆ |
| Genus | 30.9x | 2.2x | 2.80% | ★★★☆☆☆ |
We're going to check out a few of the best picks from our screener tool.
Simply Wall St Value Rating: ★★★★☆☆
Overview: AK Medical Holdings specializes in the design, development, and manufacturing of orthopedic implants, with operations primarily in China and the United Kingdom, and has a market capitalization of CN¥9.52 billion.
Operations: The company generates revenue primarily from orthopedic implants in China and the United Kingdom, with total revenues reaching CN¥1.48 billion as of December 2025. The gross profit margin has shown fluctuations, peaking at 70.78% in December 2017 and standing at 60.54% by the end of December 2025. Operating expenses are significant, including sales and marketing, R&D, and general administrative costs contributing to overall financial performance.
PE: 15.1x
AK Medical Holdings, a smaller player in the medical device industry, is catching attention with insider confidence reflected by Xiaohong Zhao's purchase of 200,000 shares valued at approximately HK$1.02 million. Recent corporate guidance highlights a promising increase in revenue and net profit for the first half of 2026, driven by robust overseas sales and intelligent devices. Despite relying on higher-risk external borrowing for funding, AK Medical's growth trajectory suggests potential value as it expands its market reach globally.
Evaluate AK Medical Holdings' historical performance by accessing our past performance report.
Simply Wall St Value Rating: ★★★☆☆☆
Overview: Sagicor Financial is a financial services company operating in life insurance, investment, and banking across various regions including Canada, the USA, and Jamaica, with a market capitalization of approximately $1.52 billion.
Operations: Sagicor Financial generates revenue primarily from its segments in Jamaica, Canada, and Life Insurance operations. The company has seen fluctuations in its gross profit margin, with a notable increase to 62.58% by June 2025. Operating expenses have varied over time, impacting net income margins which reached 10.04% by September 2025.
PE: 33.0x
Sagicor Financial, a smaller player in the financial sector, faces challenges with its funding structure relying solely on external borrowing. Despite recent earnings reporting a net loss of US$34 million for Q1 2026, insider confidence is evident as Gilbert Palter purchased 50,000 shares valued at approximately US$400K. The company plans to repurchase up to 9.2 million shares by June 2027, signaling potential value recognition despite current profit margin pressures and uncovered interest payments.
Gain insights into Sagicor Financial's past trends and performance with our Past report.
Simply Wall St Value Rating: ★★★★★☆
Overview: Tenaz Energy is engaged in the production and sale of petroleum and natural gas with a market capitalization of CA$1.2 billion.
Operations: Tenaz Energy generates revenue primarily from the production and sale of petroleum and natural gas, with recent quarterly revenue reaching CA$399.00 million. The company experienced fluctuations in its gross profit margin, which was 58.64% in the latest period. Operating expenses have been a significant cost component, including depreciation and amortization expenses of CA$153.20 million for the same period. Net income margin also showed variability, standing at 52.59% recently due to notable non-operating expense adjustments.
PE: 8.9x
Tenaz Energy, a smaller player in the energy sector, recently reported Q1 2026 revenue of C$131.16 million, a significant jump from C$16.29 million the previous year. However, it also faced a net loss of C$111.08 million compared to last year's C$5.31 million loss. Despite insider confidence shown through recent share purchases, the company deals with high debt levels and relies on external borrowing for funding. Revenue growth is expected at 31% annually; however, earnings may decline by 5% over three years due to financial challenges and past shareholder dilution concerns.
Examine Tenaz Energy's past performance report to understand how it has performed in the past.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com